Bioatla Stock Market Value
| BCAB Stock | USD 1.68 0.04 2.44% |
| Symbol | Bioatla |
Bioatla Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioatla. If investors know Bioatla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioatla listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.70) | Revenue Per Share 0.228 | Quarterly Revenue Growth 0.316 | Return On Assets (0.50) | Return On Equity (1.39) |
The market value of Bioatla is measured differently than its book value, which is the value of Bioatla that is recorded on the company's balance sheet. Investors also form their own opinion of Bioatla's value that differs from its market value or its book value, called intrinsic value, which is Bioatla's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioatla's market value can be influenced by many factors that don't directly affect Bioatla's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioatla's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bioatla is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioatla's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bioatla 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bioatla's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bioatla.
| 11/02/2024 |
| 12/02/2024 |
If you would invest 0.00 in Bioatla on November 2, 2024 and sell it all today you would earn a total of 0.00 from holding Bioatla or generate 0.0% return on investment in Bioatla over 30 days. Bioatla is related to or competes with Pmv Pharmaceuticals, C4 Therapeutics, Nautilus Biotechnology, Century Therapeutics, Passage Bio, Ikena Oncology, and Olema Pharmaceuticals. BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics f... More
Bioatla Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bioatla's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bioatla upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.98 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 31.41 | |||
| Value At Risk | (7.59) | |||
| Potential Upside | 12.86 |
Bioatla Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioatla's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bioatla's standard deviation. In reality, there are many statistical measures that can use Bioatla historical prices to predict the future Bioatla's volatility.| Risk Adjusted Performance | 0.0178 | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.92) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0398 |
Bioatla Backtested Returns
At this point, Bioatla is risky. Bioatla secures Sharpe Ratio (or Efficiency) of 0.0061, which signifies that the company had a 0.0061% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Bioatla, which you can use to evaluate the volatility of the firm. Please confirm Bioatla's Downside Deviation of 4.98, risk adjusted performance of 0.0178, and Mean Deviation of 4.44 to double-check if the risk estimate we provide is consistent with the expected return of 0.0361%. The firm shows a Beta (market volatility) of 1.51, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bioatla will likely underperform. Bioatla right now shows a risk of 5.94%. Please confirm Bioatla maximum drawdown, semi variance, and the relationship between the sortino ratio and potential upside , to decide if Bioatla will be following its price patterns.
Auto-correlation | -0.46 |
Modest reverse predictability
Bioatla has modest reverse predictability. Overlapping area represents the amount of predictability between Bioatla time series from 2nd of November 2024 to 17th of November 2024 and 17th of November 2024 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bioatla price movement. The serial correlation of -0.46 indicates that about 46.0% of current Bioatla price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.46 | |
| Spearman Rank Test | -0.14 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Bioatla lagged returns against current returns
Autocorrelation, which is Bioatla stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bioatla's stock expected returns. We can calculate the autocorrelation of Bioatla returns to help us make a trade decision. For example, suppose you find that Bioatla has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bioatla regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bioatla stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bioatla stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bioatla stock over time.
Current vs Lagged Prices |
| Timeline |
Bioatla Lagged Returns
When evaluating Bioatla's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bioatla stock have on its future price. Bioatla autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bioatla autocorrelation shows the relationship between Bioatla stock current value and its past values and can show if there is a momentum factor associated with investing in Bioatla.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bioatla offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bioatla's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bioatla Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bioatla Stock:Check out Bioatla Correlation, Bioatla Volatility and Bioatla Alpha and Beta module to complement your research on Bioatla. For information on how to trade Bioatla Stock refer to our How to Trade Bioatla Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Bioatla technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.